Brief: Invivo Therapeutics Names Robert J. Rosenthal As A Director, Effective Immediately - SEC Filing
Nov 12 (Reuters) - InVivo Therapeutics Holdings Corp
NVIV.O :
* INVIVO THERAPEUTICS - ON NOV 8 BOARD ELECTED ROBERT J.
ROSENTHAL, PH.D. AS A DIRECTOR, EFFECTIVE IMMEDIATELY - SEC
FILING
Source : (https://bit.ly/2Cy1CuG)
Further company coverage: NVIV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InVivo Therapeutics Holdings
See all newsU.S. STOCKS ON THE MOVE-Gold miners, Dorian LPG, Apple
U.S. STOCKS ON THE MOVE-CMS Energy, SunPower, Etsy
InVivo Therapeutics falls on filing for Chapter 11 bankruptcy
Brief: InVivo Therapeutics Holdings Received Notice Of Delisting Or Failure To Satisfy Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Alibaba, Cisco, CRISPR